December 29, 2025

HER2-Positive Early Breast Cancer: Trastuzumab Deruxtecan Moves Into Earlier Clinical Settings

Two pivotal studies of fam-trastuzumab deruxtecan-nxki (T-DXd) in early HER2-positive breast cancer suggest this antibody-drug conjugate (targeting the HER2 protein) may be moving into the curative se...

The ASCO Post

December 19, 2025

Atlanta ‘veneer tech’ indicted on more than 100 charges

A man who claimed to be a “veneer technician” is facing more than 100 charges after he allegedly practiced dentistry without a license.

ADA News

December 18, 2025

FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer

The PARP inhibitor was approved for adults with deleterious BRCA mutation–associated metastatic castration-resistant prostate cancer previously treated with an androgen receptor–directed therapy.

The ASCO Post

December 15, 2025

ADA seeks representative for American Medical Association advisory committee

Nominations for the primary adviser position will be open from Jan. 15 to Feb. 15, 2026.

ADA News

December 12, 2025

Mobile Health Tool Helps Improve Quality of Life For Young Breast Cancer Survivors

dolescent and young adult breast cancer survivors who used a novel mobile health (mHealth) intervention to self-manage post-treatment symptoms and concerns were able to improve their quality of life and reduce the burden of common symptoms compared to patients who received usual care, according to results from a new clinical trial being reported at the 2025 San Antonio Breast Cancer Symposium (SABCS).

Dana-Farber

December 09, 2025

Navigating DED with Seasoned Patients

As dry eye becomes more complex with age, optometrists can better navigate DED in seasoned patients with a holistic, individualized approach

The Ophthalmologist

December 05, 2025

Project DISARM: New Cancer Mission Emphasizes Risk Assessment and Early Detection of Ovarian Cancer

Often referred to as a “silent killer,” ovarian cancer is the most lethal of female cancers. Issues of late detection and poor survival rates continue to persevere, leading to increasing levels of inc...

The ASCO Post

December 04, 2025

HPV Testing Shift: New Screening Guidance

The American Cancer Society’s updated cervical cancer screening guideline introduces FDA-approved self-collected HPV testing and clearer exit criteria.

Conexiant

December 03, 2025

NCOIL approves 'opt-in' amendment to Transparency in Dental Benefits Contracting Model Act

The National Council of Insurance Legislators voted to approve amendments to the 2020 Transparency in Dental Benefits Contracting Model Act.

ADA News